| scholarly article | Q13442814 |
| P2093 | author name string | J Nilsson | |
| P K Shah | |||
| D Hopkins | |||
| E Bengtsson | |||
| R Alm | |||
| R Corder | |||
| A Lahiri | |||
| G N Fredrikson | |||
| D V Anand | |||
| P2860 | cites work | Determinants of Progression of Coronary Artery Calcification in Type 2 Diabetes | Q58562514 |
| Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits | Q71231757 | ||
| Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease | Q71730634 | ||
| Oxidized lipids in atherogenesis: formation, destruction and action | Q73447357 | ||
| Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits | Q73914311 | ||
| Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications | Q74440973 | ||
| The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice | Q74598506 | ||
| Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus | Q74612236 | ||
| Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study | Q77948236 | ||
| Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events | Q79533802 | ||
| Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease | Q79961506 | ||
| Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression | Q80417831 | ||
| Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy | Q82646206 | ||
| The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects | Q83304478 | ||
| Atherosclerosis. the road ahead | Q29618972 | ||
| The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy? | Q31119010 | ||
| Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease | Q31135767 | ||
| Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences | Q31135771 | ||
| LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis | Q31807216 | ||
| Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis | Q33890402 | ||
| Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality | Q34215254 | ||
| Immunomodulation of atherosclerosis: implications for vaccine development | Q34363173 | ||
| Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis | Q34737721 | ||
| Innate and acquired immunity in atherogenesis | Q34986341 | ||
| Oxidized phospholipids as modulators of inflammation in atherosclerosis | Q35539436 | ||
| Grading and disease management in national screening for diabetic retinopathy in England and Wales | Q35591048 | ||
| Lipids and lipoproteins in patients with type 2 diabetes | Q35783120 | ||
| Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies | Q35888472 | ||
| CD1d-dependent activation of NKT cells aggravates atherosclerosis. | Q36399122 | ||
| The immune response in atherosclerosis: a double-edged sword | Q36508676 | ||
| Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. | Q36817686 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| Risk of macular degeneration in users of statins: cross sectional study. | Q37085714 | ||
| Autoimmunity in atherosclerosis: a protective response losing control? | Q37138017 | ||
| Inflammation and immunity in diabetic vascular complications | Q37260195 | ||
| IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
| Prevention and treatment of the complications of diabetes mellitus | Q40496478 | ||
| Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease | Q43788592 | ||
| Autoantibodies against modified low-density lipoproteins in coronary artery disease | Q44125644 | ||
| Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy | Q44219630 | ||
| Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis | Q44608860 | ||
| Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients | Q44633955 | ||
| Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways | Q44807760 | ||
| Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis | Q45232086 | ||
| High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction | Q46457217 | ||
| Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis | Q47788311 | ||
| Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. | Q50847890 | ||
| P433 | issue | 7 | |
| P921 | main subject | autoantibody | Q785022 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 1426-1433 | |
| P577 | publication date | 2009-05-12 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes | |
| P478 | volume | 52 |
| Q53333802 | Abnormal myocardial perfusion in the absence of anatomically significant coronary artery disease: implications and clinical significance. |
| Q59335211 | Associations between circulating IgG antibodies to Apolipoprotein B-derived peptide antigens and acute coronary syndrome in a Chinese Han population |
| Q37770113 | Atherosclerosis, diabetes and lipoproteins |
| Q38152732 | B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance |
| Q37728724 | B cells as under-appreciated mediators of non-auto-immune inflammatory disease |
| Q33942560 | B lymphocytes as emerging mediators of insulin resistance |
| Q35175305 | Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women |
| Q49409256 | Clinical and Pathological Significance of Autoantibodies to Erythropoietin Receptor in Type 2 Diabetic Patients With CKD. |
| Q49072554 | Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus. |
| Q36042620 | Detection of circulating IgG antibodies to apolipoprotein B100 in acute myocardial infarction |
| Q37549608 | Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy |
| Q37143813 | Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes. |
| Q33930928 | High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes |
| Q37716355 | Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes |
| Q33942486 | Modified Lipoproteins in Diabetic Retinopathy: A Local Action in the Retina |
| Q38316537 | Obesity modulates the immune response to oxidized LDL in hypertensive patients. |
| Q30390555 | PPARalpha: an emerging therapeutic target in diabetic microvascular damage. |
| Q35998510 | Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention |
| Q36117585 | Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers. |
| Q37372290 | Proteomic Insight Reveals Elevated Levels of Albumin in Circulating Immune Complexes in Diabetic Plasma |
| Q92340615 | Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment |
| Q37851349 | State of the union between metabolism and the immune system in type 2 diabetes. |
| Q37925018 | Targeting inflammation in cardiovascular diseases. still a neglected field? |
| Q37974553 | The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance |
| Q38089941 | Vaccines against atherosclerosis |
Search more.